Reversible splenial lesion syndrome: A differential diagnosis of corpus callosum lesions
- PMID: 32288299
- PMCID: PMC7125732
- DOI: 10.1016/j.npbr.2018.07.004
Reversible splenial lesion syndrome: A differential diagnosis of corpus callosum lesions
Figures

References
-
- Doherty M.J., Jayadev S., Watson N.F., Konchada R.S., Hallam D.K. Clinical implications of splenium magnetic resonance imaging signal changes. Archives of Neurology. 2005;62:433–437. - PubMed
-
- Garcia-Monco J.C., Escalza Cortina I., Ferreira E., Martinez A., Ruiz L. Reversible Splenial Lesion Syndrome (RESLES): What’s in a Name? Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging. 2011;21:e1–e14. - PubMed
-
- Garg N., Reddel S.W., Miller D.H., Chataway J., Riminton D.S., Barnett Y. The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases. Journal of Neurology, Neurosurgery, and Psychiatry. 2015;86(12):1374–1382. - PubMed
-
- Hoshino A., Saitoh M., Oka A., Okumura A., Kubota M., Saito Y. Epidemiology of acute encephalopathyin Japan, with emphasis on the association of viruses and syndromes. Brain & Development. 2012;34(05):337–343. - PubMed
-
- Pan J.J., Zaho Y., Lu C., Hu Y., Yang Y. Mild encephalitis/encephalopathy with a reversible splenial lesion: Five cases and a literature review. Neurological Science. 2015;36(11):2043–2051. - PubMed
LinkOut - more resources
Full Text Sources